ReviewPediatric dermatology
Adverse Childhood Experiences and Pediatric Dermatology: Implications for Care, Equity, and Research.
Review in Pediatric dermatology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Adverse childhood experiences (ACEs) are increasingly recognized as important determinants of lifelong physical and mental health through mechanisms involving chronic stress, immune dysregulation, and inflammation. Although ACEs have been associated with numerous chronic medical conditions, their relevance to pediatric dermatology has received comparatively little attention. Existing evidence directly linking ACEs to dermatologic disease is limited and focuses primarily on atopic dermatitis and psoriasis, while research involving other pediatric skin disorders has largely examined psychosocial stress, trauma, or social drivers of health using heterogeneous frameworks. This fragmented approach limits the ability to compare findings across conditions and to understand how cumulative early-life adversity influences disease onset, severity, treatment response, and quality of life. In this commentary, we review the current evidence connecting ACEs and dermatologic disease, distinguish ACEs from broader social drivers of health, and identify critical gaps in the pediatric dermatology literature. We discuss methodological considerations for incorporating ACE measures into pediatric dermatology research and outline practical, trauma-informed approaches for integrating awareness of early-life adversity into clinical care. Pediatric dermatologists care for children during the developmental period in which ACEs occur and often develop long-term therapeutic relationships, positioning the specialty to advance understanding of how cumulative adversity shapes skin disease trajectories. Greater incorporation of ACE-informed frameworks into research and clinical practice may improve understanding of pediatric skin disease and support more holistic, patient-centered care.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.